మా గ్రూప్ ప్రతి సంవత్సరం USA, యూరప్ & ఆసియా అంతటా 3000+ గ్లోబల్ కాన్ఫరెన్స్ ఈవెంట్లను నిర్వహిస్తుంది మరియు 1000 కంటే ఎక్కువ సైంటిఫిక్ సొసైటీల మద్దతుతో 700+ ఓపెన్ యాక్సెస్ జర్నల్లను ప్రచురిస్తుంది , ఇందులో 50000 మంది ప్రముఖ వ్యక్తులు, ప్రఖ్యాత శాస్త్రవేత్తలు ఎడిటోరియల్ బోర్డ్ సభ్యులుగా ఉన్నారు.
ఎక్కువ మంది పాఠకులు మరియు అనులేఖనాలను పొందే ఓపెన్ యాక్సెస్ జర్నల్స్
700 జర్నల్స్ మరియు 15,000,000 రీడర్లు ప్రతి జర్నల్ 25,000+ రీడర్లను పొందుతున్నారు
Ranveer Rajat
Neurodegenerative disorders represent a heterogeneous group of chronic and progressive conditions characterized by the degeneration and loss of function of neurons in the central nervous system. These disorders encompass a wide range of conditions, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), and various forms of dementia. The etiology of neurodegenerative disorders is multifactorial, involving genetic, environmental, and age-related factors. The hallmark of neurodegenerative disorders is the gradual and irreversible loss of neurons, leading to cognitive decline, motor dysfunction, and a decline in overall quality of life. Aberrant protein aggregation, mitochondrial dysfunction, oxidative stress, and neuroinflammation are among the common pathological mechanisms observed in these disorders. The clinical manifestations vary widely, reflecting the specific regions of the brain affected and the predominant neuronal populations involved. Current diagnostic approaches for neurodegenerative disorders often rely on clinical assessments, neuroimaging, and biomarker analyses. Despite advances in understanding the molecular and cellular underpinnings of these conditions, effective disease-modifying treatments remain elusive. Therapeutic interventions primarily aim at symptom management and slowing disease progression, emphasizing the importance of early and accurate diagnosis. This comprehensive review explores the diverse landscape of neurodegenerative disorders, encompassing their epidemiology, clinical manifestations, underlying pathophysiological mechanisms, diagnostic modalities, and current therapeutic strategies. Additionally, emerging research directions, including precision medicine approaches, neuroprotective strategies, and potential disease-modifying interventions, are discussed. The interdisciplinary nature of neurodegenerative disorder research is highlighted, emphasizing the need for collaboration among clinicians, neuroscientists, geneticists, and other stakeholders to advance our understanding and develop effective therapeutic interventions.